ITM Signs Clinical Supply Agreement with Y-mAbs for n.c.a. Lutetium-177
July 21, 2022 05:21 ET
|
ITM Isotope Technologies Munich SE
ITM to supply its medical radioisotope, no-carrier-added Lutetium-177, for the clinical development of Y-mAbs’ Targeted Radionuclide Therapy candidate GD2-SADA: 177Lu-DOTA Complex for GD2-positive...
ITM: New Isotope Production System at Bruce Power Successfully Produces First Medical Isotope
June 21, 2022 11:45 ET
|
ITM Isotope Technologies Munich SE
First-of-a-kind Isotope Production System continues to progress towards commercial, industrial-scale production of medical isotopes for cancer therapeutics ONTARIO, CANADA, and MUNICH, GERMANY – June...
Breast Cancer Society of Canada Grants $250,000 To Precision Oncology Research at Dalhousie University
June 15, 2022 10:32 ET
|
The Breast Cancer Society of Canada
SARNIA, Ontario, June 15, 2022 (GLOBE NEWSWIRE) -- The Breast Cancer Society of Canada (BCSC) today announced $250,000 in funding to the Department of Biochemistry and Molecular Biology, Faculty of...
Breast Cancer Society of Canada Grants $350,000 To Precision Oncology Research
May 25, 2022 09:24 ET
|
The Breast Cancer Society of Canada
SARNIA, Ontario, May 25, 2022 (GLOBE NEWSWIRE) -- The Breast Cancer Society of Canada (BCSC) today announced the recipients of their first-ever Breast Cancer Research request for proposals....
NERx Biosciences to Present New Data Highlighting Their Pre-clinical Pipeline of Drugs Targeting the DNA Damage Response at American Association For Cancer Research Annual Meeting in April
March 30, 2022 07:00 ET
|
NERx Biosciences
INDIANAPOLIS, March 30, 2022 (GLOBE NEWSWIRE) -- NERx Biosciences, an oncology company led by John Turchi and Katherine Pawelczak, will be presenting on two pre-clinical pipeline drugs that may have...
Global Oncology Precision Medicine Market to 2031 - Focus on Ecosystem and Application
March 30, 2022 05:08 ET
|
Research and Markets
Dublin, March 30, 2022 (GLOBE NEWSWIRE) -- The "Oncology Precision Medicine Market - A Global and Regional Analysis: Focus on Ecosystem and Application - Analysis and Forecast, 2020-2031" report has...
Global Precision Medicine Software Market Outlook & Forecast Report 2022-2027 Featuring Syapse, AccessDx Laboratory, Fabric Genomics, Foundation Medicine, Intel, and IBM
February 08, 2022 05:33 ET
|
Research and Markets
Dublin, Feb. 08, 2022 (GLOBE NEWSWIRE) -- The "Precision Medicine Software Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The precision...
Outlook on the Genomic Cancer Panel and Profiling Global Market - Featuring 10x Genomics, Abbott Diagnostics and AccuraGen Among Others
January 28, 2022 05:13 ET
|
Research and Markets
Dublin, Jan. 28, 2022 (GLOBE NEWSWIRE) -- The "Genomic Cancer Panel and Profiling Markets by Cancer, by Application, by Tissue and by Gene Type with Screening potential Market Size,...
Global Genomic Cancer Panel and Profiling Markets, 2012-2022 & 2025: Level of Care, Factors Limiting Growth, Diagnostic Technology Development
January 17, 2022 04:43 ET
|
Research and Markets
Dublin, Jan. 17, 2022 (GLOBE NEWSWIRE) -- The "Genomic Cancer Panel and Profiling Markets by Cancer and Germline/Somatic Type with Screening Potential Market Size, Customized Forecasting/Analysis,...
Curesponse Secures Additional USD 8 Million Funding for Its Breakthrough Precision Oncology Platform
November 15, 2021 14:35 ET
|
Curesponse
REẖOVOT, Israel, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Curesponse (www.curesponse.com) has secured additional USD 8 million funding for its breakthrough precision oncology platform. Curesponse is a...